Norwood Medical Corporation Sustainability Profile
Norwood Medical Corporation, a leading name in the medical device industry, is headquartered in the United States. Founded in 1997, the company has established itself as a key player in the development and manufacturing of innovative medical solutions, particularly in the fields of surgical instruments and advanced wound care products. With a strong operational presence across North America and Europe, Norwood Medical is renowned for its commitment to quality and precision. The company’s core offerings include custom surgical instruments and proprietary wound care technologies, which are distinguished by their reliability and effectiveness. Norwood Medical has achieved significant milestones, including ISO certification and partnerships with major healthcare providers, solidifying its market position as a trusted supplier in the medical sector.
DitchCarbon Score
How does Norwood Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Norwood Medical Corporation's score of 43 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Norwood Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Heraeus Holding GmbH, which may influence its climate commitments and emissions reporting. As of now, Norwood Medical Corporation has not established any documented reduction targets or climate pledges. However, it is important to note that emissions data and climate initiatives may be cascaded from its parent company, Heraeus Holding GmbH. This relationship could potentially align Norwood Medical with broader sustainability goals and initiatives set by Heraeus. In the absence of specific emissions figures, Norwood Medical Corporation's commitment to addressing climate change remains unclear. The company may benefit from leveraging the sustainability frameworks and targets established by Heraeus Holding GmbH, which could enhance its environmental performance in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 20,488,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 40,897,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 00,000,000,000 |
How Carbon Intensive is Norwood Medical Corporation's Industry?
How Carbon Intensive is Norwood Medical Corporation's Location?
Norwood Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Norwood Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
